Semaglutide evidence & pricing journal
Ten in-depth, source-backed briefings on compounded semaglutide — the clinical trial data, the safety profile, the regulatory rules, and the cost math — each written to be genuinely useful before you spend a dollar. Reviewed by Adam Kennah, M.D.
How we rank. RxCompareHub is affiliate-supported and may have a business or referral relationship with providers it reviews. Rankings are editorial; providers cannot pay for placement. Compounded semaglutide is not FDA-approved. Details checked July 2026 — verify with each provider. Not medical advice.
Clinical evidenceSemaglutide clinical trial results explainedThe STEP program in plain language — the pivotal 14.9% result, two-year durability, and cost-per-result.Safety & scienceSemaglutide side effects & how to manage themSide effects by trial frequency, why they cluster at titration, the boxed warning, and a management plan.ScienceHow semaglutide works: the GLP-1 scienceThe mechanism behind the results — appetite, gastric emptying, glucose control — and oral vs injectable.Long-termWeight regain after stopping semaglutideTwo-thirds of weight returns within a year of stopping — the data and the 5-year cost math.ComparisonSemaglutide vs tirzepatide: cost & efficacySURMOUNT-5 efficacy, the pricing gap, and a cost-per-result framework to decide which fits.CardiovascularSemaglutide & cardiovascular outcomes: SELECTA 20% reduction in heart attacks and strokes, and why it changes the coverage argument.Regulatory503A vs 503B compounded semaglutideTwo legal compounding categories, why the resolved shortage narrowed the rules, and how to verify.Value analysisCompounded vs brand semaglutideDifferent regulatory categories, not the same drug at different prices — with the insurance path.State guideCompounded semaglutide cost by state (2026)Why compounded pricing is national but access is local — plus the HSA/FSA tax angle.Dosing guideSemaglutide dosing, titration & cost by doseThe 0.25–2.4 mg ladder and why flat-rate pricing matters more with every escalation.